Detalles de la búsqueda
1.
Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF Inhalation.
Respiration
; 102(2): 101-109, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36502800
2.
Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung Fibrosis.
Am J Respir Cell Mol Biol
; 67(3): 320-333, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696344
3.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
N Engl J Med
; 381(10): 923-932, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483963
4.
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.
Curr Issues Mol Biol
; 43(1): 389-404, 2021 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34205365
5.
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Genet Med
; 21(1): 44-52, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29543226
6.
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Genet Med
; 21(8): 1900, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209272
7.
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Genet Med
; 21(2): 512-515, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190610
8.
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Genet Med
; 21(5): 1263, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30728527
9.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.
N Engl J Med
; 382(2): 198, 2020 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914250
10.
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study.
Pharmacoepidemiol Drug Saf
; 26(10): 1182-1189, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28752672
11.
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
BMC Pulm Med
; 17(1): 40, 2017 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212655
12.
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosis.
Am J Physiol Lung Cell Mol Physiol
; 308(2): L105-17, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398988
13.
Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.
BMC Pulm Med
; 15: 88, 2015 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26264717
14.
Low concentrations of recombinant granulocyte macrophage-colony stimulating factor derived from Chinese hamster ovary cells augments long-term bioactivity with delayed clearance in vitro.
Cytokine
; 68(2): 118-26, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24813650
15.
Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells.
J Immunol
; 188(11): 5408-20, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22551552
16.
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.
BMC Pulm Med
; 14: 37, 2014 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24597668
17.
Modified eosinophil adhesion in pulmonary alveolar proteinosis caused by CSF2RA deletion.
Allergol Int
; 68S: S14-S16, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31303308
18.
Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
Clin Immunol
; 149(3): 357-64, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24211842
19.
Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Infect Dis (Lond)
; 55(12): 857-873, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729076
20.
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.
ERJ Open Res
; 9(1)2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601310